Results 41 to 50 of about 3,220,825 (277)

Biosimilar tenecteplase versus alteplase in acute ischemic stroke: A real world study

open access: yesAnnals of Indian Academy of Neurology, 2023
Background and Purpose: There is an unmet need for a more effective thrombolytic agent in acute ischemic stroke (AIS) management. Various studies and meta-analysis suggest tenecteplase (TNK) as non-inferior over alteplase (rTPA).
Ayush Mohan   +11 more
doaj   +1 more source

Effects Of Attenuation And Thrombus Age On The Success Of Ultrasound And Microbubble-Mediated Thrombus Dissolution [PDF]

open access: yes, 2011
The purpose of this study was to examine the effects of applied mechanical index, incident angle, attenuation and thrombus age on the ability of 2-D vs. 3-D diagnostic ultrasound and microbubbles to dissolve thrombi.
Drvol, L. K.   +8 more
core   +3 more sources

Food Origin Fibrinolytic Enzyme With Multiple Actions

open access: yesHayati Journal of Biosciences, 2018
Many health related problems such as cardiovascular diseases are associated with the formation of excessive clot in the blood (thrombus). Approaches in cardiovascular disease treatment are preventing the formation or removing the thrombus.
Laurentia Stephani   +5 more
doaj   +1 more source

Effects of moderate weight loss on anginal symptoms and indices of coagulation and fibrinolysis in overweight patients with angina pectoris [PDF]

open access: yes, 2002
Objective: To evaluate the effects of moderate weight loss, in overweight patients with angina, on plasma coagulation, fibrinolytic indicies and pain frequency.
Hankey, C.R.   +4 more
core   +1 more source

Food Origin Fibrinolytic Enzyme With Multiple Actions

open access: yesHayati Journal of Biosciences, 2017
Many health related problems such as cardiovascular diseases are associated with the formation of excessive clot in the blood (thrombus). Approaches in cardiovascular disease treatment are preventing the formation or removing the thrombus.
Laurentia Stephani   +5 more
doaj   +1 more source

Fibrinolytic Enzyme from Green Microalgae: A New Potential Drug for Thrombolytic Therapy?

open access: yesPhycology, 2023
Thrombosis is characterized by the pathological formation of fibrin clots within a blood vessel, leading to the obstruction of blood flow. Fibrinolytic enzymes from microorganisms have been shown to be more efficient and safer in dissolving clots.
Yanara Alessandra Santana Moura   +5 more
doaj   +1 more source

Admission Tpe interval predicts reperfusion success in STEMI patients treated with fibrinolytic agents

open access: yesTürk Kardiyoloji Derneği Arşivi, 2020
Objective: Myocardial infarction is a leading cause of morbidity and mortality. Fibrinolytic administration is still a life-saving choice in ST-segment elevated myocardial infarction (STEMI), but the rate of successful reperfusion can be inconsistent ...
Ali Çoner   +4 more
doaj   +1 more source

NATTOKINASE – USES AND BENEFITS [PDF]

open access: yesTrakia Journal of Sciences, 2023
Nattokinase has been one of the most widely discussed and researched extracellular enzymes since it was first introduced in 2005. Nattokinase belongs to the subtilisin family and is a proteolytic enzyme (serine protease) with a powerful fibrinolytic ...
M. Hristova
doaj   +1 more source

Spectrophotometric analysis of thrombolytic activity: SATA assay [PDF]

open access: yes, 2017
Introduction: Measurement of thrombolytic activity i.e. clot lysis is crucial for research and development of novel thrombolytics. It is also a key factor in assessment of the effectiveness of conventionally used thrombolytic agents in the clinic, which ...
Entekhabi, Nazila   +5 more
core   +2 more sources

The study of the pharmacological activity of thick extract from the leaves of Corylus avellana on the model of peripheral vascular thrombophlebitis in rabbit ear

open access: yesAktualʹnì Pitannâ Farmacevtičnoï ì Medičnoï Nauki ta Praktiki, 2017
Creation of accessible domestic drug for the treatment and prevention of thrombotic venous damage, which would be able to adjust maximum range of disorders with minimal side effects, is actual direction of the pharmacology.
L. M. Maloshtan, A. S. Kalenichenko
doaj   +1 more source

Home - About - Disclaimer - Privacy